Insilico Medicine Raises $60 Million in Series D Financing to ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEW YORK, June 6, 2022 /PRNewswire-AsiaNet/ -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with expertise in investing in t...
Authors: LATEST ASIANET NEWS RELEASES